Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgitte Holst

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Journal of Affective Disorders|December 10, 2014
GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?Katarzyna Młyniec, Nicolas Singewald, Birgitte Holst, et al.
Frontiers in Endocrinology|October 14, 2021
Biased Ghrelin Receptor Signaling and the Dopaminergic System as Potential Targets for Metabolic and Psychological Symptoms of Anorexia NervosaMariam S Khelifa, Louise J Skov, Birgitte Holst
The Journal of Biological Chemistry|September 24, 2002
Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptorsBirgitte Holst, Christian E Elling, Thue W Schwartz
International Journal of Molecular Sciences|April 30, 2021
The Zinc-Sensing Receptor GPR39 in Physiology and as a Pharmacological TargetAnna Laitakari, Lingzhi Liu, Thomas M Frimurer, et al.
Molecular Informatics|August 6, 2016
In Silico Investigation of the Neurotensin Receptor 1 Binding Site: Overlapping Binding Modes for Small Molecule Antagonists and the Endogenous Peptide AgonistMichael Lückmann, Birgitte Holst, Thue W Schwartz, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 10, 2009
Modifying the conserved C-terminal tyrosine of the peptide hormone PYY3-36 to improve Y2 receptor selectivitySøren L Pedersen, Birgitte Holst, Niels Vrang, et al.
The International Journal of Neuropsychopharmacology|January 23, 2015
GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampusKatarzyna Młyniec, Bogusława Budziszewska, Birgitte Holst, et al.
Molecular Endocrinology (Baltimore, Md.)|May 21, 2005
Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signalingBirgitte Holst, Erik Brandt, Anders Bach, et al.
Neuroendocrinology|October 10, 2009
Risperidone treatment increases CB1 receptor binding in rat brainAnna Secher, Henriette Husum, Birgitte Holst, et al.
The Journal of Biological Chemistry|November 9, 2012
PheVI:09 (Phe6.44) as a sliding microswitch in seven-transmembrane (7TM) G protein-coupled receptor activationLouise Valentin-Hansen, Birgitte Holst, Thomas M Frimurer, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Journal of Affective Disorders|December 10, 2014
GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?Katarzyna Młyniec, Nicolas Singewald, Birgitte Holst, et al.
Frontiers in Endocrinology|October 14, 2021
Biased Ghrelin Receptor Signaling and the Dopaminergic System as Potential Targets for Metabolic and Psychological Symptoms of Anorexia NervosaMariam S Khelifa, Louise J Skov, Birgitte Holst
The Journal of Biological Chemistry|September 24, 2002
Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptorsBirgitte Holst, Christian E Elling, Thue W Schwartz
International Journal of Molecular Sciences|April 30, 2021
The Zinc-Sensing Receptor GPR39 in Physiology and as a Pharmacological TargetAnna Laitakari, Lingzhi Liu, Thomas M Frimurer, et al.
Molecular Informatics|August 6, 2016
In Silico Investigation of the Neurotensin Receptor 1 Binding Site: Overlapping Binding Modes for Small Molecule Antagonists and the Endogenous Peptide AgonistMichael Lückmann, Birgitte Holst, Thue W Schwartz, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 10, 2009
Modifying the conserved C-terminal tyrosine of the peptide hormone PYY3-36 to improve Y2 receptor selectivitySøren L Pedersen, Birgitte Holst, Niels Vrang, et al.
The International Journal of Neuropsychopharmacology|January 23, 2015
GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampusKatarzyna Młyniec, Bogusława Budziszewska, Birgitte Holst, et al.
Molecular Endocrinology (Baltimore, Md.)|May 21, 2005
Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signalingBirgitte Holst, Erik Brandt, Anders Bach, et al.
Neuroendocrinology|October 10, 2009
Risperidone treatment increases CB1 receptor binding in rat brainAnna Secher, Henriette Husum, Birgitte Holst, et al.
The Journal of Biological Chemistry|November 9, 2012
PheVI:09 (Phe6.44) as a sliding microswitch in seven-transmembrane (7TM) G protein-coupled receptor activationLouise Valentin-Hansen, Birgitte Holst, Thomas M Frimurer, et al.
Pageof 13